Evaluation of Exposure and Effects in Human Session: Biomarkers in Environmental Health Research & Practice

References

• National Research Council. Committee on Biological Markers, Biological markers in environmental health research. Environ Health Perspect (1987); 74: 3–9
   PubMed Web of Science ®Google Scholar
• Links JM, Kensler TW, Groopman JD. Biomarkers and mechanistic approaches in environmental epidemiology. Annu Rev Public Health (1995); 16: 83–103
   PubMed Web of Science ®Google Scholar
• Wogan GN. Molecular Epidemiology in cancer risk assessment and prevention: Recent progress and avenues for future research. Environ Health Perspect (1997); 98: 167–178
   Google Scholar
• Hulka B. Epidemiological studies using biological markers: Issues for epidemiologists. Cancer Epidemiol, Biomarkers, andPrev (1991); 1: 13–19
   PubMed Web of Science ®Google Scholar
• Campbell AA, Whitaker TB, Pohland AE, Dickens JW, Park DL. Sampling sample preparation, and sampling plans for foodstuffs for mycotoxin analysis. Pure and Applied Chemistry (1986); 58: 305–314
   Web of Science ®Google Scholar
• Rappaport SM, Kure E, Petreas M, Ting D, Woodlee J. A field method for measuring solvent vapors in exhaled air: Application to styrene exposure. Scand J Work Environ Health (1991); 3: 195–204
   Google Scholar
• Wolff MS, Toniolo PG, Lee EW, Rivera M, Dubin N. Blood levels of organochlorine residues and risk of breast cancer. J Nat Cancer Inst (1993); 85: 648–652
   PubMed Web of Science ®Google Scholar
• Krieger N, Wolff MS, Hiatt RA, Rivera M, Vogelman J Orentreich. Breast cancer and serum organochlorines: A prospective study among white, black, and Asian women. J Nat Can Inst (1994); 86: 589–599
   PubMed Web of Science ®Google Scholar
• Hecht SS, Haley NJ, Hoffmann D. Monitoring exposure to tobacco products by measurement of nicotine metabolites and derived carcinogens. Molecular Dosimetry and Human Cancer, PL Skipper. CRC Press, Boca Raton (1991); 325–362
   Google Scholar
• Hecht SS, Carmella SG, Foiles PG, Murphy SE. Biomarkers for human uptake and metabolic activation of tobacco-specific nitrosamines. Cancer Research (1994); 54: 1912s–1917s
   PubMed Web of Science ®Google Scholar
• Carmella SG, Akerkar S, Hecht SS. Metabolites of the tobacco-specific nitrosamine 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone in smokers'urine. CancerRes (1993); 53: 721–724
   Web of Science ®Google Scholar
• Cohen N, Spitz HB, Wrenn ME. Estimation of skeletal burden of “bone-seeking” radionuclides in man from in vivo scintillation measurements of the head. Health Physics (1977); 30: 431–441
   Google Scholar
• Somervaille LJ, Chettle DR, Scott MC. In vivo measurement of lead in bone using x-ray fluorescence. Phys Med Biol (1985); 30: 929–943
   PubMed Web of Science ®Google Scholar
• Hu H, Milder FL, Burger DE. X-ray fluorescence: Issues surrounding the application of a new tool for measuring burden of lead. Environ Research (317); 317: 295–317
   Google Scholar
• Kaderlik RK, Lin DX, Lang NP, Kadlubar FF. Advantages and limitations of laboratory methods for measurement of carcinogen-DNA adducts for epidemiological studies. Toxicol Letters (1992); 64-65: 469–475
   PubMed Web of Science ®Google Scholar
• Bartsch H, Malaveille C, Friesen M, Kadlubar FF, Vineis P. Black and blond tobacco cancer risk. IV: Molecular dosimetry studies implicate aromatic amines as bladder carcinogens. Eur J Cancer (1993); 29A: 1199–1207
   PubMed Web of Science ®Google Scholar
• Shuker DE, Farmer PB. Relevance of urinary DNA adducts as markers of carcinogen exposure. Chem Res Toxicol (1992); 5: 450–460
   PubMed Web of Science ®Google Scholar
• Groopman JD, Hasler J, Trudel LJ, Pikul A, Donahue PR, Wogan GN. Molecular dosimetry in rat urine of aflatoxin-N7-guanine and other aflatoxin metabolites by multiple monoclonal antibody affinity chromatography and HPLC. Cancer Res (1992); 52: 267–274
   PubMed Web of Science ®Google Scholar
• Groopman JD, Wogan GN, Roebuck BD, Kensler TW. Molecular biomarkers for aflatoxins and their application to human cancer prevention. Cancer Research (1994); 54: 1907s–1911s
   PubMed Web of Science ®Google Scholar
• Groopman JD, Zhu J, Donahue PR, Pikul A, Zhang L-S, Chen J-S, Wogan GN. Molecular dosimetry of urinary aflatoxin DNA adducts in people living in Guangxi Autonomous Region, People's Republic of China. Cancer Res (1992); 52: 45–51
   PubMed Web of Science ®Google Scholar
• Tannenbaum SR. Hemoglobin-carcinogen adducts as molecular biomarkers in epidemiology, Princess Takamatsu Symposia. Japan Scientific Society Press, Tokyo (1990); 351–360
   Google Scholar
• Hammond SK, Coghlin J, Gann PH, Paul M, Taghiza-Deh K, Skipper PL, Tannenbaum SR. Relationship between environmental tobacco smoke exposure and carcinogen-hemoglobin adduct levels in nonsmokers. J Nat Cancer Inst (478); 478: 474–478
   Google Scholar
• Schauer DA, Desrosiers MF, Le FG, Seltzer SM, Links JM. EPR dosimetry of cortical bone and tooth enamel irradiated with X and gamma rays: Study of energy dependence. Rod Research (1994); 138: 1–8
   PubMed Web of Science ®Google Scholar
• Dockery DW, Speizer FE, Ferris BG, Ware JH, Louis TA, Spiro A. Cumulative and reversible effects of lifetime smoking and simple tests of lung function in adults. Am Rev Resp Dis (1988); 137: 286–292
   PubMed Web of Science ®Google Scholar
• Laube BL, Bowes SM, Links JM, Thomas KK, Frank R. Acute exposure to acid fog: Effects on mucociliary clearance. Am Rev Resp Dis (1993); 147: 1105–1111
   PubMed Web of Science ®Google Scholar
• Lang NP, Kadlubar FF. Aromatic and heterocyclic amine metabolism and phenotyping in humans. Prog Clin Biol Res (1991); 372: 33–47
   PubMedGoogle Scholar
• Caporaso N, Landi MT, Vineis P. Relevance of metabolic polymorphisms to human carcinogenesis: evaluation of epidemiologic evidence. Pharmacogenetics (1991); 1: 4–19
   PubMedGoogle Scholar
• Butler MA, Lang NP, Young JF, Caporaso NE, Vineis P, Hayes RB, Teitel CH, Massengill JP, Lawsen MF, Kadlubar FF. Determination of CYP1A2 and acetyltransferase phenotypes in human populations by analysis of caffeine urinary metabolites. Pharmacogenetics (1992); 2: 116–127
   PubMedGoogle Scholar
• Athas WF, Hedayati MA, Matanoski GM, Farmer ER, Grossman L. Development and field-test validation of an assay for DNA repair in circulating human lymphocytes. Cancer Res (1991); 51: 5786–5793
   PubMed Web of Science ®Google Scholar
• Kleeberger SR, Bassett DJP, Jakab GJ, Levitt RC. A genetic model for evaluation of susceptibility to ozone-induced inflammation. JAppl Physiol (1990); 258: L313–L320
   Web of Science ®Google Scholar
• Sidransky D. Identification of p53 gene mutations in bladder cancers and urine samples. Science (1991); 252: 706
   PubMed Web of Science ®Google Scholar
• Sidransky D, Tokino T, Hamilton SR, Kinzler KW, Levin B, Frost P, Vogelstein B. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science (1992); 256: 102–105
   PubMed Web of Science ®Google Scholar